Developing a New Region-Specific Preference-Based Measure in East and Southeast Asia.

East and Southeast Asia preference-based measure qualitative study quality-adjusted life years

Journal

Value in health regional issues
ISSN: 2212-1102
Titre abrégé: Value Health Reg Issues
Pays: United States
ID NLM: 101592642

Informations de publication

Date de publication:
Nov 2022
Historique:
received: 21 01 2022
revised: 31 05 2022
accepted: 25 07 2022
pubmed: 14 9 2022
medline: 9 11 2022
entrez: 13 9 2022
Statut: ppublish

Résumé

Almost all preference-based measures (PBMs) have been developed in Western countries, with none having been formulated in Asian countries. In this study, we construct a new generic PBM based on concept elicitation using interview surveys in East and Southeast Asian countries and qualitative analysis. This cross-sectional study included 225 adults recruited from 9 East and Southeast Asian countries or regions (Indonesia, Japan, Korea, mainland China, Malaysia, the Philippines, Singapore, Taiwan, and Thailand). Trained interviewers conducted semistructured interviews with 25 participants from the general population of each country/region. Qualitative data were analyzed using a content analysis approach. The selection of items was determined based on interview surveys and team member discussions. The description of items was considered based on a detailed qualitative analysis of the interview survey. A new region-specific PBM-the Asia PBM 7 dimensions instrument-was designed. It reflects East and Southeast Asian values and comprises 7 items: pain, mental health, energy, mobility, work/school, interpersonal interactions, and burden to others. The new region-specific instrument is one of the first PBMs developed in the context of non-Western countries. The Asia PBM 7 dimensions contains 7 items that address the core concepts of health-related quality of life that are deemed important based on East and Southeast Asian health concepts.

Identifiants

pubmed: 36099801
pii: S2212-1099(22)00133-9
doi: 10.1016/j.vhri.2022.07.002
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

62-69

Informations de copyright

Copyright © 2022 International Society for Health Economics and Outcomes Research. Published by Elsevier Inc. All rights reserved.

Auteurs

Takeru Shiroiwa (T)

Center for Outcomes Research and Economic Evaluation for Health, National Institute of Public Health, Wako, Japan. Electronic address: t.shiroiwa@gmail.com.

Tatsunori Murata (T)

Crecon Medical Assessment Co, Ltd, Tokyo, Japan.

Jeonghoon Ahn (J)

Department of Health Convergence, Ewha Womans University, Seoul, Republic of Korea.

Xue Li (X)

China National Health Development Research Center, Beijing, China.

Ryota Nakamura (R)

Hitotsubashi Institute for Advanced Study, Hitotsubashi University, Kunitachi, Japan.

Yot Teerawattananon (Y)

Health Intervention and Technology Assessment Program, Ministry of Public Health, Nonthaburi, Thailand; Saw Swee Hock School of Public Health, National University of Singapore, Singapore.

Zhao Kun (Z)

China National Health Development Research Center, Beijing, China.

Asrul Akmal Shafie (AA)

School of Pharmaceutical Sciences, Universiti Sains Malaysia, Penang, Malaysia.

Haidee Valverde (H)

Institute of Health Policy and Development Studies, University of the Philippines Manila, National Institutes of Health, Manila, Philippines.

Hilton Lam (H)

Institute of Health Policy and Development Studies, University of the Philippines Manila, National Institutes of Health, Manila, Philippines.

Kwong Ng (K)

Agency for Care Effectiveness, Ministry of Health Singapore, Singapore.

Mardiati Nadjib (M)

ThinkWell, Jakarta, Indonesia; Department of Health Policy and Administration, University of Indonesia, Depok, Indonesia.

Raoh-Fang Pwu (RF)

National Hepatitis C Program Office, Ministry of Health and Welfare, Taipei, Taiwan.

Ryan Rachmad Nugraha (RR)

Center for Health Economics and Policy Studies, School of Public Health University of Indonesia, Depok, Indonesia.

Yong-Chen Chen (YC)

Master Program of Big Data in Biomedicine, College of Medicine, Fu Jen Catholic University, New Taipei City, Taiwan.

Takashi Fukuda (T)

Center for Outcomes Research and Economic Evaluation for Health, National Institute of Public Health, Wako, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH